NMS Capital Forms Flourish Research and Recapitalizes Clinical Trials of Texas
August 12, 2021
NMS Capital formed a new platform, Flourish Research, and completed a recapitalization of Clinical Trials of Texas (CTT) in partnership with founder Kay Scroggins and company management. The deal makes CTT the inaugural partner in a buy-and-build strategy to create a nationwide network of clinical research sites; CTT is headquartered in San Antonio, Texas, operates a 20,000+ sq. ft. facility and has conducted over 1,000 trials across more than 15 therapeutic areas.
- Buyers
- NMS Capital, Flourish Research
- Targets
- Clinical Trials of Texas
- Platforms
- Flourish Research
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.